PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 73 filers reported holding PHARMATHENE INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $10,603,000 | -54.2% | 3,262,422 | -59.1% | 2.23% | -54.8% |
Q3 2016 | $23,145,000 | +18.9% | 7,981,035 | 0.0% | 4.94% | +5.3% |
Q2 2016 | $19,474,000 | +29.1% | 7,981,035 | 0.0% | 4.69% | +30.6% |
Q1 2016 | $15,084,000 | -0.5% | 7,981,035 | 0.0% | 3.59% | +3.2% |
Q4 2015 | $15,164,000 | +42.9% | 7,981,035 | 0.0% | 3.48% | +35.9% |
Q3 2015 | $10,615,000 | -26.1% | 7,981,035 | 0.0% | 2.56% | -10.4% |
Q2 2015 | $14,366,000 | +10.4% | 7,981,035 | 0.0% | 2.86% | +9.4% |
Q1 2015 | $13,009,000 | -9.9% | 7,981,035 | 0.0% | 2.61% | +10.8% |
Q4 2014 | $14,446,000 | +1.7% | 7,981,035 | 0.0% | 2.36% | -15.8% |
Q3 2014 | $14,206,000 | +92.1% | 7,981,035 | +52.2% | 2.80% | +115.4% |
Q2 2014 | $7,395,000 | -23.0% | 5,244,835 | 0.0% | 1.30% | -28.2% |
Q1 2014 | $9,598,000 | -1.6% | 5,244,835 | 0.0% | 1.81% | -2.2% |
Q4 2013 | $9,755,000 | -11.4% | 5,244,835 | 0.0% | 1.85% | -20.7% |
Q3 2013 | $11,014,000 | +47.7% | 5,244,835 | +11.8% | 2.34% | +33.4% |
Q2 2013 | $7,458,000 | – | 4,690,724 | – | 1.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 520,000 | $422,000 | 0.44% |
FIRST QUADRANT LLC/CA | 1,655,539 | $1,343,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 1,118,005 | $907,000 | 0.02% |
CIGNA INVESTMENTS INC /NEW | 303,239 | $246,000 | 0.02% |
Burt Wealth Advisors | 17,870 | $15,000 | 0.01% |
Sullivan, Bruyette, Speros & Blaney, LLC | 126,346 | $103,000 | 0.01% |
ClariVest Asset Management LLC | 322,970 | $262,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 594,444 | $482,000 | 0.01% |
Renaissance Technologies | 4,790,931 | $3,888,000 | 0.01% |
Mraz, Amerine & Associates, Inc. | 20,000 | $15,000 | 0.01% |